Masimo (MASI)
(Delayed Data from NSDQ)
$108.09 USD
-0.90 (-0.83%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $108.05 -0.04 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Masimo Corporation [MASI]
Reports for Purchase
Showing records 401 - 420 ( 486 total )
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Looking Up for Rainbow - Consistent Outlook; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
3Q Preview: Expecting Inline Q, Guidance Unchanged
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare - 3Q 2012: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Investor Day: Built for Long-Term; LT Risk-Reward Attractive-Buy at Right Price
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Revs Up for SET & PHASEIN, EPS Outlook Down Only Modestly; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
MASI Q2 revenue beat, EPS missed, PHASEIN acquired, EPS guidance reduced
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Masimo Corporation
Industry: Medical - Instruments
REITS BUY -Q2 CONSENSUS $ 0.28, ABOVE OUR EST OF $0.24
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare - 2Q 2012: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare: Med Tech: The Vote Is In - ACA Upheld; Device Tax a Headwind into 2013
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Distribution Deal Boosts Growth Opportunity for Rainbow; Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M